Drugs / Lacteol fort
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05283278 | Feb 2020 → Mar 2021 | fungal infectious disease | Ain Shams University | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT04603456 | Sep 2018 → Mar 2019 | allergic rhinitis | Zagazig University | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lacteol fort | “the probiotic Lactobacillus Delbrueckii and Lactobacillus Fermentum (Lacteol fort®) given in a dose of 5 billions starting from birth to the 30th day of life for neonates in group B” NCT05283278 ↗ |